Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Global Vaccines Market 2008-2023
2.
Global Biotech Market Analysis and Forecasts, 2008-2023
3.
Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies Markets, Companies and Opportunities
4.
Picture Archiving and Communications Systems (PACS)
5.
Microarray Markets
6.
Medical Nanotechnology Markets
7.
Contract Manufacturing Opportunities in High-Growth Medical Devices (Catheters, Pacemakers, LVADs, Hip and Knee Implants, Air Pathways, Syringes)
8.
Infusion Pump Markets (Large Volume, Ambulatory, Disposable, Syringe, and Specialty Infusion Pumps)
9.
Minimally Invasive Surgical Devices, World Market
10.
Innovative Strategies and Models for R&D Success: The evolving networked pharma company
Best Sellers:
1.
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, March 2008
2.
BioNewsCast Press Release Distribution Service
3.
Peripheral Neuropathy and Neuropathic Pain, 2008
4.
Blood Glucose Testing and Diabetes Management Report
5.
Autoimmune and Inflammation Rheumatoid Arthritis Drug Pipeline Report
6.
The Global Rheumatoid Arthritis Market Forecasts to 2012
7.
Biostatistics course
8.
Worldwide Surgical Sealants, Glues and Wound Closure Market, 2007-2011
9.
Good Manufacturing Practice (GMP) Course
10.
Good Clinical Practice I (GCP) course
Stakeholder Opinions: Sepsis - The Critical Care Community Gains Critical Mass
The Critical Care Community is currently at its most organized, and motivated, and on a mission to improve outcomes in sepsis. This is driving a rigorous assessment of care strategies which is gathering speed and showing results. This will yield many opportunities for developing products, but current interventions' roles will change, with impacts on how they are measured, used and valued.
Scope
Insight into clinical and commercial developments tackling predisposition, infection, response and organ dysfunction A translation of the complex, multifaceted processes involved in sepsis into commercial realities for industry Perspectives from Contract Research, Biotech, Pharmaceutical and Diagnostics sectors and leading figures from the sepsis and critical care community Assessment of the impact of the Surviving Sepsis Campaign and the changes in its latest set of guidelines on prescribing physicians
Highlights
The critical care community's rigorous assessment of current management strategies is now gathering speed and showing results, gaining more converts and highlighting new perspectives on sepsis-related processes Current interventions used in sepsis are typically either repurposed from other disease areas, or based on nascent understandings of the processes in play Whilst this improved understanding may yield many new opportunities for developing new interventions, the understanding of the roles of current interventions may be turned upside-down, with implications for how they are measured, used, and indeed, valued in improving outcomes
Reasons to Purchase
Understand the clinical and commercial characteristics and priorities for an increasingly complex therapy area Identify the elements of strategies that will either kept players at the top of their field or fail completely Understand how these businesses and strategies relate to your interest in the market, and how to position your products and services accordingly.
26-Mar-08 Format: PDF & SlidePack Pages: 124
Table of Contents
Price: $3,800.00 / GBP1,976.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.